Bicycle Therapeutics (BCYC) Interest & Investment Income (2018 - 2026)

Bicycle Therapeutics (BCYC) has 9 years of Interest & Investment Income data on file, last reported at $4.4 million in Q2 2026.

• Quarterly Interest & Investment Income fell 41.66% year-over-year to $4.4 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $21.8 million (down 40.68% YoY) and the FY2025 annual result came in at $28.5 million, down 16.98% from the prior year.
• Interest & Investment Income eased to $4.4 million in Q2 2026, from $4.9 million in the prior quarter.
• In the past five years, Interest & Investment Income ranged from a high of $10.6 million in Q3 2024 to a low of $218000.0 in Q1 2022.
• A 5-year average of $5.1 million and a median of $5.3 million in 2024 frame the typical range for Interest & Investment Income.
• Annual changes were most pronounced in 2022 — Interest & Investment Income jumped 8195.83% — and 2025, when it sank 42.97%.
• Tracing BCYC's Interest & Investment Income over 5 years: stood at $2.6 million in 2022, then soared by 137.82% to $6.3 million in 2023, then surged by 64.17% to $10.3 million in 2024, then sank by 42.97% to $5.9 million in 2025, then decreased by 25.8% to $4.4 million in 2026.
• The last three Interest & Investment Income figures came in at $4.4 million (Q2 2026), $4.9 million (Q1 2026), and $5.9 million (Q4 2025), per Business Quant data.